About this Research Topic
Frontiers in Allergy is delighted to be launching this dedicated Research Topic to highlight World Urticaria Day on October 1st 2021. This day aims to raise awareness of chronic urticaria, a condition which negatively impacts patient quality of life with many gaps in the current knowledge.
Urticaria is classified as chronic when symptoms last 6 weeks or longer. There are various known triggers, including: allergic reactions; infections; and exposure to heat/cold. However, the cause of chronic urticaria often remains unknown. World Urticaria Day presents the opportunity to focus on this major challenge in skin allergy research and gain new insights into the causes of chronic urticaria, in order to facilitate better prevention and treatment and improve patient quality of life.
New clinical trials of various treatment strategies for chronic urticaria are targeting not only on IgE-related autoimmunity but other potential endotypes. This research plays an important role in unravelling the causes of chronic urticaria, however, all types of epidemiological study, as well as new developments in diagnostics, can add to the picture on this complex disease.
This Research Topic is led by an expert team of skin allergy specialists and showcases new discoveries in the epidemiology and diagnosis of chronic urticaria. All article types accepted by Frontiers are encouraged.
Conflict of interest declaration: Topic Editor Nicola Wagner is or recently was a speaker and/or advisor for ALK-Abelló, Novartis Pharma GmbH, Allergopharma GmbH & Co KG and Shire/Takeda, is/was involved in clinical trials of Novartis Pharma GmbH, Allergopharma GmbH & Co KG, Sanofi and has received research funding from Novartis Pharma GmbH.
Keywords: skin allergy, chronic urticaria, chronic hives, weals, epidemiology of urticaria, urticaria triggers, urticaria diagnosis
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.